| Company Name: |
TargetMol |
| Tel: |
400-821-0310 15002144251 |
| Email: |
xuexiang.shao@tsbiochem.com |
|
| | 1H-Pyrazole-3-carboxamide, 4-[(2,6-difluorobenzoyl)amino]-N-[(tetrahydro-2H-pyran-4-yl)methyl]- Basic information |
| | 1H-Pyrazole-3-carboxamide, 4-[(2,6-difluorobenzoyl)amino]-N-[(tetrahydro-2H-pyran-4-yl)methyl]- Chemical Properties |
| Boiling point | 539.9±50.0 °C(Predicted) | | density | 1.389±0.06 g/cm3(Predicted) | | solubility | DMSO: 2 mg/mL, clear | | pka | 10.80±0.70(Predicted) | | form | powder | | color | white to beige | | SMILES | O=C(NCC1CCOCC1)C2=NNC=C2NC(C3=C(C=CC=C3F)F)=O |
| | 1H-Pyrazole-3-carboxamide, 4-[(2,6-difluorobenzoyl)amino]-N-[(tetrahydro-2H-pyran-4-yl)methyl]- Usage And Synthesis |
| Uses | GSK3-IN-10 (Compound 4) is a multi-target inhibitor, that mainly targets GSK3α and GSK3β with IC50 of 1.0 nM and 2.0 nM. GSK3-IN-10 inhibits the activation of β-catenin, promotes the neuronal survival, and exhibits a protective effect against endoplasmic reticulum stress[1]. | | IC 50 | GSK-3α: 1.0 nM (IC50); GSK-3β: 2.0 nM (IC50); DYRK1B: 47 nM (IC50); DYRK1A: 170 nM (IC50); ICK: 520 nM (IC50); CLK1: 620 nM (IC50); CLK4: 760 nM (IC50); DYRK2: 800 nM (IC50); CLK2: 800 nM (IC50); CDKL5: 840 nM (IC50); JNK3: 2900 nM (IC50); CDK4: 3800 nM (IC50) | | References | [1] Ong HW, et al., Discovery of a Potent and Selective CDKL5/GSK3 Chemical Probe That Is Neuroprotective. ACS Chem Neurosci. 2023 May 3;14(9):1672-1685. DOI:10.1021/acschemneuro.3c00135 |
| | 1H-Pyrazole-3-carboxamide, 4-[(2,6-difluorobenzoyl)amino]-N-[(tetrahydro-2H-pyran-4-yl)methyl]- Preparation Products And Raw materials |
|